. 2023 Sep 5;3(9):e0000610. doi: 10.1371/journal.pgph.0000610

Table 2. Costs used in the primary and sensitivity analyses.

	Parameter	Value	Lower	Upper	Source (Main)	Source (Lower)	Source (Upper)
1	*Home testing for HIV*
	Positive test	5.81	2	20.5	Meyer-Rath, 2019 [14]	OraQuick self-test [21]	Chang, 2016 (SEARCH) [22]
	Negative test	5.23	2	20.5	Meyer-Rath, 2019 [14]	OraQuick self-test [21]	Chang, 2016 (SEARCH) [22]
2	*Annual HIV-related hospitalisation*
	CD4 <200	125.50	71.50	222.5	Meyer-Rath, 2013 [23]	Meyer-Rath, 2013 [23]	Meyer-Rath, 2013 [23]
	CD4 200–350	58	39	97
	CD4 350+	39	23	76
	On ART	45	23	80
3	*Community ART*
	First year	310.84	250	618.6	DO ART (at-scale) [6]	DO ART 6-month refill (calculated)	DO ART (as observed) [6]
	Subsequent years	245.15	199	500.88	DO ART (at-scale) [6]	DO ART 6-month refill (calculated)	DO ART (as observed) [6]
4	*Clinic ART*	249.15	109.55	315.39	Meyer-Rath, 2019 [14]	Nichols, 2021 (SDC6) [24]	Thomas, 2021 (PopART) [25]

Notes

In the analysis, all costs are inflation-adjusted to 2020 USD. Here they are presented in nominal USD for ease of reference with the literature.